| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 127 | 2021 | 348 | 15.400 |
Why?
|
| Pancreatitis | 75 | 2021 | 279 | 5.720 |
Why?
|
| Sphincterotomy, Endoscopic | 32 | 2021 | 79 | 5.460 |
Why?
|
| Sphincter of Oddi | 29 | 2021 | 51 | 4.760 |
Why?
|
| Endoscopy, Gastrointestinal | 34 | 2016 | 170 | 4.480 |
Why?
|
| Sphincter of Oddi Dysfunction | 10 | 2018 | 48 | 4.470 |
Why?
|
| Cholecystectomy | 24 | 2018 | 79 | 3.610 |
Why?
|
| Abdominal Pain | 12 | 2017 | 97 | 3.150 |
Why?
|
| Common Bile Duct Diseases | 15 | 2016 | 24 | 2.960 |
Why?
|
| Endoscopy, Digestive System | 18 | 2015 | 78 | 2.840 |
Why?
|
| Gastroenterology | 16 | 2014 | 98 | 2.760 |
Why?
|
| Gallstones | 35 | 2018 | 58 | 2.750 |
Why?
|
| Stents | 37 | 2015 | 657 | 2.740 |
Why?
|
| Clinical Competence | 14 | 2020 | 657 | 2.550 |
Why?
|
| Pancreas | 45 | 2018 | 225 | 2.450 |
Why?
|
| Biliary Tract Diseases | 20 | 2018 | 50 | 2.440 |
Why?
|
| Humans | 472 | 2022 | 68549 | 2.350 |
Why?
|
| Cholestasis | 38 | 2009 | 90 | 2.270 |
Why?
|
| Endoscopy | 86 | 2011 | 464 | 2.260 |
Why?
|
| Pancreatic Ducts | 30 | 2018 | 76 | 2.240 |
Why?
|
| Pancreatic Diseases | 23 | 2018 | 66 | 2.120 |
Why?
|
| Cholelithiasis | 29 | 2013 | 66 | 1.770 |
Why?
|
| Acquired Immunodeficiency Syndrome | 18 | 1994 | 121 | 1.650 |
Why?
|
| Endoscopes | 19 | 2015 | 36 | 1.480 |
Why?
|
| Postoperative Complications | 30 | 2019 | 1615 | 1.480 |
Why?
|
| Pain, Postoperative | 4 | 2017 | 214 | 1.440 |
Why?
|
| United States | 90 | 2018 | 7338 | 1.390 |
Why?
|
| Informed Consent | 4 | 2022 | 127 | 1.340 |
Why?
|
| Middle Aged | 143 | 2019 | 21119 | 1.200 |
Why?
|
| Female | 175 | 2019 | 38021 | 1.140 |
Why?
|
| Adult | 127 | 2019 | 21379 | 1.120 |
Why?
|
| Catheterization | 24 | 2013 | 209 | 1.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 12 | 2006 | 59 | 1.090 |
Why?
|
| Gastrointestinal Diseases | 12 | 2008 | 107 | 1.070 |
Why?
|
| Pancreatitis, Chronic | 6 | 2016 | 168 | 1.070 |
Why?
|
| Ampulla of Vater | 20 | 2005 | 34 | 1.050 |
Why?
|
| Colonoscopy | 10 | 2008 | 156 | 1.030 |
Why?
|
| Aged | 118 | 2019 | 14842 | 1.010 |
Why?
|
| Learning Curve | 2 | 2015 | 20 | 1.010 |
Why?
|
| Equipment Contamination | 3 | 2015 | 38 | 1.000 |
Why?
|
| Male | 154 | 2019 | 37283 | 1.000 |
Why?
|
| Colony Count, Microbial | 2 | 2015 | 77 | 1.000 |
Why?
|
| Cholangiography | 31 | 2016 | 55 | 0.950 |
Why?
|
| Credentialing | 3 | 2017 | 23 | 0.950 |
Why?
|
| Contrast Media | 7 | 2015 | 595 | 0.910 |
Why?
|
| Endoscopes, Gastrointestinal | 8 | 2011 | 17 | 0.890 |
Why?
|
| Patient Selection | 10 | 2012 | 592 | 0.880 |
Why?
|
| Manometry | 13 | 2021 | 276 | 0.850 |
Why?
|
| Disclosure | 1 | 2022 | 45 | 0.820 |
Why?
|
| Sphincterotomy, Transduodenal | 13 | 1991 | 24 | 0.800 |
Why?
|
| Gastrointestinal Hemorrhage | 14 | 2005 | 185 | 0.790 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2013 | 503 | 0.780 |
Why?
|
| Health Policy | 9 | 1993 | 221 | 0.780 |
Why?
|
| Quality Assurance, Health Care | 5 | 2013 | 177 | 0.770 |
Why?
|
| Gastroenterologists | 2 | 2020 | 11 | 0.770 |
Why?
|
| Gallbladder Diseases | 4 | 2010 | 16 | 0.760 |
Why?
|
| Palliative Care | 19 | 2009 | 271 | 0.740 |
Why?
|
| Bile Ducts | 13 | 1998 | 59 | 0.740 |
Why?
|
| Pain Management | 4 | 2017 | 186 | 0.730 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 51 | 0.730 |
Why?
|
| Drug Hypersensitivity | 2 | 2015 | 35 | 0.700 |
Why?
|
| Guideline Adherence | 4 | 2011 | 285 | 0.680 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2016 | 929 | 0.680 |
Why?
|
| Acute Disease | 21 | 2021 | 658 | 0.680 |
Why?
|
| Risk Assessment | 12 | 2016 | 2004 | 0.670 |
Why?
|
| Pancreatic Neoplasms | 25 | 1998 | 332 | 0.660 |
Why?
|
| Malpractice | 2 | 2010 | 15 | 0.640 |
Why?
|
| Education, Medical | 5 | 2006 | 147 | 0.640 |
Why?
|
| Lithotripsy | 6 | 2020 | 18 | 0.630 |
Why?
|
| Benchmarking | 3 | 2013 | 91 | 0.620 |
Why?
|
| HIV Infections | 12 | 1994 | 775 | 0.620 |
Why?
|
| Liability, Legal | 2 | 2015 | 19 | 0.610 |
Why?
|
| Cholestasis, Extrahepatic | 6 | 2010 | 14 | 0.610 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 122 | 0.600 |
Why?
|
| Risk Factors | 24 | 2021 | 5720 | 0.590 |
Why?
|
| Clinical Trials as Topic | 15 | 2008 | 848 | 0.590 |
Why?
|
| Common Bile Duct | 10 | 2001 | 22 | 0.590 |
Why?
|
| Retrospective Studies | 32 | 2021 | 7268 | 0.590 |
Why?
|
| Follow-Up Studies | 29 | 2015 | 3256 | 0.580 |
Why?
|
| Analgesia | 1 | 2017 | 58 | 0.580 |
Why?
|
| Biliary Dyskinesia | 1 | 2016 | 7 | 0.560 |
Why?
|
| Pancreatin | 1 | 2016 | 1 | 0.560 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2016 | 9 | 0.550 |
Why?
|
| Aged, 80 and over | 35 | 2017 | 4843 | 0.550 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2016 | 9 | 0.550 |
Why?
|
| Ultrasonography | 15 | 2016 | 453 | 0.530 |
Why?
|
| Medical Errors | 2 | 2007 | 80 | 0.530 |
Why?
|
| Bile Duct Diseases | 16 | 2006 | 28 | 0.520 |
Why?
|
| Societies, Medical | 8 | 2011 | 403 | 0.520 |
Why?
|
| Digestive System Diseases | 4 | 2000 | 16 | 0.520 |
Why?
|
| Research Design | 7 | 2010 | 729 | 0.520 |
Why?
|
| Video Recording | 4 | 2006 | 145 | 0.520 |
Why?
|
| Prospective Studies | 25 | 2017 | 3703 | 0.510 |
Why?
|
| Drainage | 14 | 1995 | 133 | 0.510 |
Why?
|
| Duodenum | 25 | 1994 | 47 | 0.500 |
Why?
|
| Biliary Tract Neoplasms | 8 | 2004 | 17 | 0.490 |
Why?
|
| Hospitals | 1 | 2017 | 265 | 0.490 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 378 | 0.490 |
Why?
|
| Time Factors | 26 | 2018 | 4655 | 0.480 |
Why?
|
| Postoperative Care | 4 | 2006 | 163 | 0.480 |
Why?
|
| Treatment Outcome | 23 | 2020 | 7028 | 0.470 |
Why?
|
| Calcinosis | 3 | 2010 | 241 | 0.470 |
Why?
|
| Violence | 5 | 1994 | 275 | 0.460 |
Why?
|
| Stomach | 12 | 2007 | 80 | 0.460 |
Why?
|
| Disease Management | 1 | 2015 | 248 | 0.460 |
Why?
|
| Terminology as Topic | 4 | 2014 | 141 | 0.460 |
Why?
|
| Bile Duct Neoplasms | 11 | 2009 | 39 | 0.450 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 3 | 2016 | 20 | 0.450 |
Why?
|
| Politics | 5 | 1993 | 31 | 0.440 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 772 | 0.440 |
Why?
|
| Zidovudine | 4 | 1994 | 27 | 0.420 |
Why?
|
| Drugs, Investigational | 4 | 1994 | 18 | 0.420 |
Why?
|
| Disability Evaluation | 2 | 2014 | 298 | 0.420 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 1994 | 92 | 0.420 |
Why?
|
| Recurrence | 22 | 2018 | 948 | 0.420 |
Why?
|
| Specialization | 2 | 2005 | 66 | 0.410 |
Why?
|
| Plastics | 2 | 2010 | 25 | 0.410 |
Why?
|
| Endosonography | 5 | 2016 | 177 | 0.400 |
Why?
|
| Swine | 22 | 2008 | 672 | 0.390 |
Why?
|
| Drug and Narcotic Control | 4 | 1994 | 15 | 0.390 |
Why?
|
| Pain | 8 | 2018 | 472 | 0.390 |
Why?
|
| Professional Practice | 1 | 2011 | 47 | 0.390 |
Why?
|
| Laparoscopy | 8 | 2007 | 237 | 0.380 |
Why?
|
| Adolescent | 34 | 2014 | 8904 | 0.380 |
Why?
|
| Colonography, Computed Tomographic | 3 | 2008 | 23 | 0.370 |
Why?
|
| Sensitivity and Specificity | 14 | 2016 | 1753 | 0.370 |
Why?
|
| Pilot Projects | 10 | 2016 | 1341 | 0.370 |
Why?
|
| Prostheses and Implants | 12 | 1991 | 159 | 0.370 |
Why?
|
| Incidence | 9 | 2019 | 1582 | 0.360 |
Why?
|
| Algorithms | 6 | 2010 | 1195 | 0.360 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 121 | 0.360 |
Why?
|
| Bile | 8 | 2002 | 35 | 0.350 |
Why?
|
| Gastroscopy | 11 | 2007 | 45 | 0.350 |
Why?
|
| Computer Simulation | 5 | 2006 | 706 | 0.350 |
Why?
|
| Suture Techniques | 6 | 2007 | 75 | 0.350 |
Why?
|
| Duodenoscopy | 13 | 1990 | 15 | 0.350 |
Why?
|
| Health Care Reform | 3 | 1994 | 62 | 0.350 |
Why?
|
| Geriatrics | 4 | 1993 | 69 | 0.350 |
Why?
|
| Pancreatic Juice | 6 | 2001 | 9 | 0.340 |
Why?
|
| Esophageal Diseases | 6 | 2005 | 95 | 0.340 |
Why?
|
| Warfare | 3 | 1994 | 58 | 0.340 |
Why?
|
| Quality Improvement | 1 | 2013 | 413 | 0.340 |
Why?
|
| Women's Health | 4 | 1994 | 148 | 0.340 |
Why?
|
| Biopsy | 9 | 2000 | 539 | 0.330 |
Why?
|
| Surgical Wound Infection | 2 | 2007 | 168 | 0.330 |
Why?
|
| Long-Term Care | 3 | 1993 | 53 | 0.330 |
Why?
|
| Iodine | 1 | 2009 | 42 | 0.330 |
Why?
|
| Gadolinium | 1 | 2009 | 88 | 0.320 |
Why?
|
| HIV | 4 | 1993 | 53 | 0.320 |
Why?
|
| Women, Working | 3 | 1993 | 10 | 0.320 |
Why?
|
| Disease Outbreaks | 3 | 1993 | 83 | 0.310 |
Why?
|
| Research | 10 | 1994 | 214 | 0.310 |
Why?
|
| Glaucoma | 3 | 1993 | 50 | 0.310 |
Why?
|
| Jejunum | 2 | 2000 | 26 | 0.310 |
Why?
|
| Mass Media | 3 | 1994 | 29 | 0.300 |
Why?
|
| National Institutes of Health (U.S.) | 8 | 1994 | 109 | 0.300 |
Why?
|
| Sexual Behavior | 3 | 1994 | 179 | 0.300 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 62 | 0.300 |
Why?
|
| Multivariate Analysis | 7 | 2016 | 1046 | 0.290 |
Why?
|
| Chronic Disease | 23 | 2002 | 1329 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 5 | 2007 | 1026 | 0.290 |
Why?
|
| Military Personnel | 3 | 1994 | 221 | 0.290 |
Why?
|
| Uterus | 1 | 2006 | 77 | 0.280 |
Why?
|
| Appendectomy | 1 | 2006 | 47 | 0.280 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 2006 | 1 | 0.280 |
Why?
|
| Young Adult | 8 | 2015 | 5710 | 0.280 |
Why?
|
| Appendicitis | 1 | 2006 | 55 | 0.270 |
Why?
|
| Cystic Duct | 3 | 1995 | 5 | 0.270 |
Why?
|
| Patient Advocacy | 2 | 2000 | 40 | 0.270 |
Why?
|
| Electrocoagulation | 8 | 2008 | 34 | 0.270 |
Why?
|
| Peptic Ulcer Hemorrhage | 7 | 2005 | 26 | 0.270 |
Why?
|
| United States Food and Drug Administration | 5 | 1993 | 131 | 0.260 |
Why?
|
| Government Regulation | 4 | 1995 | 46 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2001 | 2222 | 0.260 |
Why?
|
| Animals | 44 | 2008 | 20880 | 0.260 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2012 | 11 | 0.260 |
Why?
|
| Medicine | 1 | 2005 | 51 | 0.260 |
Why?
|
| Intestine, Small | 5 | 1997 | 89 | 0.260 |
Why?
|
| Secretin | 7 | 2008 | 18 | 0.260 |
Why?
|
| Equipment Design | 15 | 2007 | 500 | 0.260 |
Why?
|
| Plants, Toxic | 3 | 1994 | 33 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2007 | 30 | 0.260 |
Why?
|
| Logistic Models | 8 | 2016 | 1419 | 0.260 |
Why?
|
| Feasibility Studies | 13 | 2008 | 652 | 0.250 |
Why?
|
| Child | 25 | 2010 | 6401 | 0.250 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 136 | 0.250 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 1993 | 52 | 0.240 |
Why?
|
| Chemical Warfare | 2 | 1994 | 3 | 0.240 |
Why?
|
| Pregnant Women | 3 | 1994 | 50 | 0.240 |
Why?
|
| Suicide, Assisted | 2 | 1995 | 14 | 0.240 |
Why?
|
| Neuromuscular Agents | 1 | 2004 | 22 | 0.240 |
Why?
|
| Anemia, Pernicious | 4 | 1990 | 11 | 0.240 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2004 | 31 | 0.240 |
Why?
|
| General Surgery | 2 | 2005 | 95 | 0.240 |
Why?
|
| Tobacco | 3 | 1994 | 161 | 0.230 |
Why?
|
| Deglutition Disorders | 2 | 2005 | 297 | 0.230 |
Why?
|
| Apolipoproteins E | 2 | 1994 | 92 | 0.230 |
Why?
|
| Gallbladder | 2 | 1995 | 15 | 0.230 |
Why?
|
| Colonic Polyps | 2 | 2004 | 63 | 0.230 |
Why?
|
| American Medical Association | 3 | 1992 | 21 | 0.230 |
Why?
|
| Predictive Value of Tests | 8 | 2014 | 1465 | 0.230 |
Why?
|
| Therapeutic Human Experimentation | 2 | 1994 | 6 | 0.230 |
Why?
|
| Colonic Neoplasms | 2 | 2000 | 299 | 0.230 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 130 | 0.230 |
Why?
|
| Public Health | 3 | 1994 | 201 | 0.220 |
Why?
|
| Antiviral Agents | 4 | 1993 | 211 | 0.220 |
Why?
|
| Poverty | 3 | 1994 | 218 | 0.220 |
Why?
|
| Homosexuality | 2 | 1993 | 10 | 0.220 |
Why?
|
| Sigmoidoscopy | 3 | 1991 | 38 | 0.220 |
Why?
|
| Estrogens | 2 | 1994 | 173 | 0.210 |
Why?
|
| Sincalide | 2 | 2001 | 12 | 0.210 |
Why?
|
| Forecasting | 6 | 2010 | 277 | 0.210 |
Why?
|
| Methods | 19 | 1994 | 156 | 0.210 |
Why?
|
| Environmental Pollution | 2 | 1994 | 25 | 0.210 |
Why?
|
| Federal Government | 5 | 1993 | 13 | 0.210 |
Why?
|
| Employee Grievances | 2 | 1992 | 2 | 0.210 |
Why?
|
| Health Services Research | 2 | 1994 | 209 | 0.210 |
Why?
|
| Age Factors | 9 | 2009 | 1860 | 0.210 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 186 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2004 | 560 | 0.200 |
Why?
|
| Organotechnetium Compounds | 1 | 2001 | 4 | 0.200 |
Why?
|
| Gastrostomy | 4 | 2006 | 110 | 0.200 |
Why?
|
| Imino Acids | 1 | 2001 | 7 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 4 | 2010 | 186 | 0.200 |
Why?
|
| Human Rights | 4 | 1994 | 12 | 0.200 |
Why?
|
| Dyspepsia | 1 | 2001 | 8 | 0.200 |
Why?
|
| Heart Diseases | 3 | 1995 | 276 | 0.200 |
Why?
|
| Cholangitis, Sclerosing | 2 | 1991 | 9 | 0.200 |
Why?
|
| Canada | 5 | 2012 | 266 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 2 | 1993 | 69 | 0.190 |
Why?
|
| United Kingdom | 5 | 2011 | 152 | 0.190 |
Why?
|
| Radiopharmaceuticals | 1 | 2001 | 114 | 0.190 |
Why?
|
| Databases, Factual | 6 | 2018 | 621 | 0.190 |
Why?
|
| Pressure | 4 | 2015 | 252 | 0.190 |
Why?
|
| Radiography, Abdominal | 1 | 2001 | 57 | 0.190 |
Why?
|
| Teaching | 3 | 1991 | 169 | 0.190 |
Why?
|
| Liver Transplantation | 3 | 1995 | 400 | 0.190 |
Why?
|
| Substance-Related Disorders | 4 | 1994 | 1242 | 0.190 |
Why?
|
| Capsaicin | 2 | 1990 | 5 | 0.190 |
Why?
|
| Infant | 13 | 2010 | 2891 | 0.190 |
Why?
|
| Calculi | 1 | 2020 | 7 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1851 | 0.180 |
Why?
|
| Cross Infection | 4 | 2011 | 195 | 0.180 |
Why?
|
| Esophagus | 8 | 2008 | 303 | 0.180 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 119 | 0.180 |
Why?
|
| Intestinal Perforation | 3 | 2006 | 35 | 0.180 |
Why?
|
| Diagnosis, Differential | 8 | 2010 | 1140 | 0.180 |
Why?
|
| Disease Models, Animal | 10 | 2007 | 2550 | 0.180 |
Why?
|
| Telemedicine | 2 | 2006 | 699 | 0.180 |
Why?
|
| Child, Preschool | 12 | 2010 | 3187 | 0.170 |
Why?
|
| Education | 1 | 2000 | 83 | 0.170 |
Why?
|
| Esophageal Neoplasms | 4 | 2005 | 150 | 0.170 |
Why?
|
| Wounds and Injuries | 3 | 1994 | 334 | 0.170 |
Why?
|
| Hepatitis C | 2 | 1991 | 114 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2013 | 2356 | 0.170 |
Why?
|
| Sex Characteristics | 2 | 1993 | 295 | 0.170 |
Why?
|
| Peptides | 2 | 1994 | 455 | 0.170 |
Why?
|
| Esophagoscopy | 4 | 2007 | 72 | 0.170 |
Why?
|
| Information Dissemination | 3 | 2004 | 113 | 0.170 |
Why?
|
| Surgical Staplers | 2 | 2007 | 4 | 0.170 |
Why?
|
| Alzheimer Disease | 2 | 1994 | 565 | 0.170 |
Why?
|
| Radiography | 17 | 1992 | 572 | 0.170 |
Why?
|
| Health Services Needs and Demand | 2 | 2005 | 149 | 0.160 |
Why?
|
| Pregnancy | 9 | 1995 | 2334 | 0.160 |
Why?
|
| Resource Allocation | 3 | 1994 | 35 | 0.160 |
Why?
|
| Liver | 4 | 2001 | 1118 | 0.160 |
Why?
|
| Sex Factors | 6 | 2012 | 1265 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 384 | 0.160 |
Why?
|
| Esophageal Stenosis | 3 | 2005 | 36 | 0.160 |
Why?
|
| Survival Rate | 5 | 2009 | 1055 | 0.160 |
Why?
|
| Cholecystitis | 1 | 1998 | 12 | 0.160 |
Why?
|
| Cholangitis | 6 | 1995 | 15 | 0.150 |
Why?
|
| Publishing | 3 | 1993 | 89 | 0.150 |
Why?
|
| Pancreatic Fistula | 1 | 1997 | 23 | 0.150 |
Why?
|
| Fistula | 1 | 1997 | 29 | 0.150 |
Why?
|
| Gastric Mucosa | 4 | 2005 | 77 | 0.150 |
Why?
|
| Peritoneal Cavity | 2 | 2007 | 25 | 0.150 |
Why?
|
| Pleural Diseases | 1 | 1997 | 20 | 0.150 |
Why?
|
| Laparoscopes | 2 | 2007 | 8 | 0.150 |
Why?
|
| Peptic Ulcer | 5 | 1994 | 37 | 0.150 |
Why?
|
| Global Health | 2 | 1994 | 135 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2000 | 2324 | 0.150 |
Why?
|
| Lipase | 3 | 2016 | 16 | 0.150 |
Why?
|
| Stomach Neoplasms | 2 | 1990 | 64 | 0.150 |
Why?
|
| Duodenal Diseases | 8 | 1997 | 15 | 0.140 |
Why?
|
| Medically Uninsured | 3 | 1992 | 99 | 0.140 |
Why?
|
| Prognosis | 6 | 2015 | 2093 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2010 | 597 | 0.140 |
Why?
|
| Cysts | 3 | 1986 | 70 | 0.140 |
Why?
|
| Bilirubin | 2 | 2016 | 51 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 1993 | 37 | 0.140 |
Why?
|
| Choledocholithiasis | 1 | 2016 | 14 | 0.130 |
Why?
|
| Physicians, Women | 2 | 1993 | 23 | 0.130 |
Why?
|
| Internationality | 2 | 2009 | 74 | 0.130 |
Why?
|
| Jejunostomy | 2 | 2006 | 26 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 2798 | 0.130 |
Why?
|
| Risk | 8 | 2016 | 563 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 1994 | 291 | 0.130 |
Why?
|
| Norfloxacin | 1 | 1995 | 1 | 0.130 |
Why?
|
| Cholagogues and Choleretics | 1 | 1995 | 2 | 0.130 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1995 | 4 | 0.130 |
Why?
|
| Treatment Failure | 1 | 2016 | 216 | 0.130 |
Why?
|
| Smoking | 2 | 1994 | 1449 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 137 | 0.130 |
Why?
|
| Drug Utilization | 3 | 2010 | 119 | 0.130 |
Why?
|
| Orthopedics | 3 | 1991 | 88 | 0.130 |
Why?
|
| Digestive System Neoplasms | 3 | 1990 | 13 | 0.130 |
Why?
|
| Diagnostic Imaging | 3 | 2006 | 201 | 0.130 |
Why?
|
| Gastroplasty | 2 | 2007 | 63 | 0.130 |
Why?
|
| Biliary Fistula | 1 | 1995 | 3 | 0.130 |
Why?
|
| Liver Function Tests | 3 | 2016 | 114 | 0.130 |
Why?
|
| State Health Plans | 2 | 1992 | 13 | 0.130 |
Why?
|
| Medicaid | 3 | 1993 | 301 | 0.130 |
Why?
|
| Liver Abscess | 1 | 1995 | 9 | 0.130 |
Why?
|
| Prosthesis Design | 4 | 2009 | 301 | 0.130 |
Why?
|
| Medical Records | 2 | 1995 | 121 | 0.130 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 1995 | 3 | 0.130 |
Why?
|
| Fiber Optic Technology | 14 | 1987 | 40 | 0.130 |
Why?
|
| Research Subjects | 2 | 1993 | 45 | 0.130 |
Why?
|
| Medicine in the Arts | 1 | 1994 | 7 | 0.130 |
Why?
|
| Streptococcus | 1 | 2014 | 15 | 0.130 |
Why?
|
| Candida | 1 | 2014 | 15 | 0.130 |
Why?
|
| Homicide | 2 | 1992 | 59 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2015 | 26 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 1991 | 226 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 1995 | 104 | 0.120 |
Why?
|
| Interferon-beta | 1 | 1994 | 17 | 0.120 |
Why?
|
| Enterococcus | 1 | 2014 | 29 | 0.120 |
Why?
|
| AIDS Vaccines | 1 | 1994 | 7 | 0.120 |
Why?
|
| Didanosine | 2 | 1991 | 3 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 938 | 0.120 |
Why?
|
| Equipment Reuse | 2 | 2011 | 7 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2009 | 880 | 0.120 |
Why?
|
| Bicarbonates | 4 | 2010 | 21 | 0.120 |
Why?
|
| Physician's Role | 4 | 2001 | 116 | 0.120 |
Why?
|
| Hypersensitivity | 2 | 1994 | 52 | 0.120 |
Why?
|
| Computer Graphics | 2 | 1991 | 37 | 0.120 |
Why?
|
| National Health Insurance, United States | 1 | 1994 | 6 | 0.120 |
Why?
|
| Ethics, Medical | 1 | 1995 | 86 | 0.120 |
Why?
|
| Common Bile Duct Neoplasms | 3 | 1995 | 12 | 0.120 |
Why?
|
| Clozapine | 2 | 1991 | 46 | 0.120 |
Why?
|
| Drug Industry | 2 | 1992 | 54 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 1995 | 83 | 0.120 |
Why?
|
| Cost Savings | 1 | 2014 | 110 | 0.120 |
Why?
|
| Condoms | 1 | 1994 | 67 | 0.120 |
Why?
|
| Fluoroscopy | 3 | 2013 | 152 | 0.120 |
Why?
|
| Computer-Assisted Instruction | 2 | 1992 | 74 | 0.120 |
Why?
|
| Diverticulum | 2 | 1991 | 29 | 0.120 |
Why?
|
| Taxes | 1 | 1994 | 31 | 0.120 |
Why?
|
| Animal Testing Alternatives | 1 | 1993 | 5 | 0.120 |
Why?
|
| Animal Experimentation | 1 | 1993 | 3 | 0.120 |
Why?
|
| Blindness | 2 | 1990 | 22 | 0.120 |
Why?
|
| Industry | 1 | 1994 | 28 | 0.120 |
Why?
|
| Peer Review | 1 | 1993 | 16 | 0.120 |
Why?
|
| Narcotics | 1 | 2014 | 65 | 0.120 |
Why?
|
| Portal Vein | 1 | 1994 | 46 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 1995 | 824 | 0.120 |
Why?
|
| Arteriosclerosis | 1 | 1994 | 137 | 0.120 |
Why?
|
| Mental Disorders | 2 | 1993 | 659 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 1994 | 40 | 0.120 |
Why?
|
| Obesity, Morbid | 2 | 2007 | 172 | 0.120 |
Why?
|
| Congresses as Topic | 2 | 2010 | 85 | 0.120 |
Why?
|
| Arbovirus Infections | 1 | 1993 | 1 | 0.120 |
Why?
|
| Disease Reservoirs | 1 | 1993 | 7 | 0.120 |
Why?
|
| Molecular Biology | 1 | 1993 | 31 | 0.120 |
Why?
|
| Neural Tube Defects | 1 | 1993 | 27 | 0.110 |
Why?
|
| Disease Vectors | 1 | 1993 | 8 | 0.110 |
Why?
|
| Genetic Testing | 1 | 1995 | 159 | 0.110 |
Why?
|
| Retinitis | 1 | 1993 | 2 | 0.110 |
Why?
|
| United States Environmental Protection Agency | 1 | 1993 | 5 | 0.110 |
Why?
|
| Zinc | 1 | 1994 | 73 | 0.110 |
Why?
|
| tau Proteins | 1 | 1994 | 61 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 1995 | 166 | 0.110 |
Why?
|
| Physician-Patient Relations | 2 | 1993 | 261 | 0.110 |
Why?
|
| Double-Blind Method | 3 | 2014 | 1738 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 1993 | 31 | 0.110 |
Why?
|
| Fetus | 1 | 1994 | 157 | 0.110 |
Why?
|
| Homes for the Aged | 1 | 1993 | 16 | 0.110 |
Why?
|
| Philosophy | 1 | 1993 | 4 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 1993 | 31 | 0.110 |
Why?
|
| Retroviridae | 1 | 1993 | 29 | 0.110 |
Why?
|
| Antigens, Viral | 1 | 1993 | 35 | 0.110 |
Why?
|
| Medicare | 2 | 2010 | 316 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 1994 | 132 | 0.110 |
Why?
|
| Memory | 1 | 1994 | 214 | 0.110 |
Why?
|
| Nursing Homes | 1 | 1993 | 54 | 0.110 |
Why?
|
| Trypsinogen | 1 | 2012 | 7 | 0.110 |
Why?
|
| Claudins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1992 | 9 | 0.110 |
Why?
|
| International Cooperation | 2 | 2009 | 88 | 0.110 |
Why?
|
| Lactates | 1 | 1992 | 29 | 0.110 |
Why?
|
| Neurophysiology | 1 | 1993 | 17 | 0.110 |
Why?
|
| Population Surveillance | 1 | 1994 | 285 | 0.110 |
Why?
|
| Huntington Disease | 1 | 1992 | 15 | 0.110 |
Why?
|
| Insurance Benefits | 1 | 1992 | 6 | 0.110 |
Why?
|
| Attitude to Death | 1 | 1993 | 52 | 0.110 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1993 | 85 | 0.110 |
Why?
|
| Voluntary Programs | 1 | 2012 | 9 | 0.110 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 2077 | 0.110 |
Why?
|
| Rural Health | 1 | 1993 | 66 | 0.110 |
Why?
|
| Behavior | 1 | 1993 | 59 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 2 | 2003 | 96 | 0.110 |
Why?
|
| Trypsin | 1 | 2012 | 64 | 0.110 |
Why?
|
| Motorcycles | 1 | 1992 | 5 | 0.110 |
Why?
|
| Microglia | 1 | 1994 | 143 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 786 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 239 | 0.110 |
Why?
|
| Jaundice | 5 | 1994 | 13 | 0.110 |
Why?
|
| Data Collection | 2 | 1994 | 420 | 0.110 |
Why?
|
| Riots | 1 | 1992 | 1 | 0.110 |
Why?
|
| Head Protective Devices | 1 | 1992 | 15 | 0.110 |
Why?
|
| United States Public Health Service | 1 | 1992 | 4 | 0.110 |
Why?
|
| Osteoporosis | 2 | 1991 | 88 | 0.110 |
Why?
|
| Coronary Artery Bypass | 1 | 1993 | 218 | 0.110 |
Why?
|
| Air Pollutants | 1 | 1993 | 75 | 0.110 |
Why?
|
| Science | 1 | 1992 | 15 | 0.110 |
Why?
|
| Sterilization | 2 | 2011 | 29 | 0.100 |
Why?
|
| Biliary Tract | 4 | 1997 | 17 | 0.100 |
Why?
|
| Mortality | 1 | 1993 | 162 | 0.100 |
Why?
|
| Thermography | 1 | 1992 | 20 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 1992 | 173 | 0.100 |
Why?
|
| Random Allocation | 8 | 2000 | 442 | 0.100 |
Why?
|
| Fraud | 1 | 1992 | 8 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2003 | 272 | 0.100 |
Why?
|
| Disinfection | 2 | 2011 | 112 | 0.100 |
Why?
|
| Intubation | 6 | 2007 | 20 | 0.100 |
Why?
|
| Urban Health | 1 | 1992 | 49 | 0.100 |
Why?
|
| Cimetidine | 3 | 1982 | 25 | 0.100 |
Why?
|
| Interprofessional Relations | 3 | 2005 | 188 | 0.100 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1991 | 2 | 0.100 |
Why?
|
| Cocaine | 2 | 1994 | 555 | 0.100 |
Why?
|
| Patient Credit and Collection | 1 | 1991 | 7 | 0.100 |
Why?
|
| Guanidines | 3 | 1982 | 32 | 0.100 |
Why?
|
| Health Education | 1 | 1994 | 279 | 0.100 |
Why?
|
| Esophagitis | 3 | 2005 | 45 | 0.100 |
Why?
|
| Patient Identification Systems | 1 | 1991 | 18 | 0.100 |
Why?
|
| Measles | 1 | 1991 | 6 | 0.100 |
Why?
|
| Polyps | 2 | 2008 | 12 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 1994 | 180 | 0.100 |
Why?
|
| Metals | 3 | 2004 | 100 | 0.100 |
Why?
|
| Case Management | 1 | 2012 | 46 | 0.100 |
Why?
|
| Immunotherapy | 1 | 1993 | 215 | 0.100 |
Why?
|
| Biomedical Research | 2 | 1993 | 310 | 0.100 |
Why?
|
| Firearms | 1 | 1992 | 26 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 1994 | 419 | 0.100 |
Why?
|
| Colonic Diseases, Functional | 1 | 1991 | 9 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2012 | 220 | 0.100 |
Why?
|
| Medical Indigency | 1 | 1991 | 7 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 1991 | 33 | 0.100 |
Why?
|
| Schizophrenia | 2 | 1991 | 206 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 1991 | 63 | 0.100 |
Why?
|
| Health Benefit Plans, Employee | 1 | 1991 | 7 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 1991 | 9 | 0.100 |
Why?
|
| Nerve Regeneration | 1 | 1991 | 42 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 737 | 0.100 |
Why?
|
| Splenic Artery | 3 | 2005 | 16 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 236 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 1 | 1991 | 25 | 0.100 |
Why?
|
| Maternal Health Services | 1 | 1991 | 22 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 429 | 0.100 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1991 | 13 | 0.100 |
Why?
|
| Cystadenoma | 1 | 1991 | 10 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2006 | 144 | 0.100 |
Why?
|
| Disasters | 1 | 1993 | 204 | 0.100 |
Why?
|
| Congenital Abnormalities | 2 | 1992 | 42 | 0.100 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1990 | 1 | 0.100 |
Why?
|
| Herpesvirus 6, Human | 1 | 1990 | 1 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1991 | 18 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 951 | 0.100 |
Why?
|
| Mycoplasma | 1 | 1990 | 10 | 0.100 |
Why?
|
| Patient Rights | 1 | 1991 | 11 | 0.100 |
Why?
|
| Intraoperative Complications | 3 | 2004 | 129 | 0.100 |
Why?
|
| Parent-Child Relations | 1 | 1991 | 98 | 0.090 |
Why?
|
| Health Care Costs | 1 | 1994 | 346 | 0.090 |
Why?
|
| Stomach Diseases | 4 | 1987 | 22 | 0.090 |
Why?
|
| Allergy and Immunology | 1 | 1990 | 9 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 1991 | 86 | 0.090 |
Why?
|
| Consumer Advocacy | 1 | 1990 | 6 | 0.090 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 72 | 0.090 |
Why?
|
| Marijuana Smoking | 1 | 1992 | 108 | 0.090 |
Why?
|
| Light Coagulation | 1 | 1990 | 4 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 136 | 0.090 |
Why?
|
| Treatment Refusal | 1 | 1991 | 40 | 0.090 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1991 | 47 | 0.090 |
Why?
|
| Quinolinic Acids | 1 | 1990 | 6 | 0.090 |
Why?
|
| Epilepsy | 1 | 1994 | 336 | 0.090 |
Why?
|
| History, 20th Century | 4 | 1992 | 248 | 0.090 |
Why?
|
| AIDS Dementia Complex | 1 | 1990 | 20 | 0.090 |
Why?
|
| Sudden Infant Death | 1 | 1990 | 6 | 0.090 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 1990 | 1 | 0.090 |
Why?
|
| Haemophilus influenzae | 1 | 1990 | 16 | 0.090 |
Why?
|
| Neurotoxins | 1 | 1990 | 30 | 0.090 |
Why?
|
| Schools, Medical | 1 | 1991 | 157 | 0.090 |
Why?
|
| Retreatment | 1 | 2010 | 59 | 0.090 |
Why?
|
| Specimen Handling | 2 | 1994 | 46 | 0.090 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 51 | 0.090 |
Why?
|
| Hospital Units | 1 | 2010 | 21 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 1990 | 67 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 1990 | 33 | 0.090 |
Why?
|
| Government Agencies | 3 | 1994 | 12 | 0.090 |
Why?
|
| Spinal Cord | 1 | 1991 | 244 | 0.090 |
Why?
|
| Bacterial Vaccines | 1 | 1990 | 32 | 0.090 |
Why?
|
| Quality of Life | 4 | 2012 | 1515 | 0.090 |
Why?
|
| Fractures, Ununited | 1 | 1990 | 16 | 0.090 |
Why?
|
| Sensation | 1 | 1990 | 49 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 1990 | 74 | 0.090 |
Why?
|
| Pancreatic Pseudocyst | 2 | 1992 | 24 | 0.090 |
Why?
|
| Nicotine | 1 | 1993 | 350 | 0.090 |
Why?
|
| Community-Institutional Relations | 1 | 1990 | 59 | 0.090 |
Why?
|
| Surgical Instruments | 2 | 1989 | 44 | 0.090 |
Why?
|
| Social Responsibility | 2 | 2005 | 39 | 0.090 |
Why?
|
| Alcoholism | 3 | 1995 | 1109 | 0.090 |
Why?
|
| Job Description | 1 | 1990 | 23 | 0.090 |
Why?
|
| Diabetic Retinopathy | 1 | 1990 | 110 | 0.090 |
Why?
|
| Bone Development | 1 | 1990 | 37 | 0.090 |
Why?
|
| Duodenoscopes | 1 | 1989 | 7 | 0.090 |
Why?
|
| Insurance, Health | 2 | 2007 | 200 | 0.090 |
Why?
|
| Knee Prosthesis | 1 | 1990 | 64 | 0.090 |
Why?
|
| Radionuclide Imaging | 3 | 2001 | 166 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1990 | 59 | 0.090 |
Why?
|
| Vocabulary, Controlled | 1 | 2009 | 13 | 0.090 |
Why?
|
| Klebsiella Infections | 1 | 2009 | 13 | 0.090 |
Why?
|
| Klebsiella pneumoniae | 1 | 2009 | 18 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2008 | 1549 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 1425 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 281 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 1990 | 58 | 0.090 |
Why?
|
| Education, Medical, Graduate | 3 | 2000 | 214 | 0.090 |
Why?
|
| Physicians | 1 | 1993 | 324 | 0.090 |
Why?
|
| Self Care | 1 | 2012 | 252 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2012 | 267 | 0.080 |
Why?
|
| Asthma | 1 | 1993 | 345 | 0.080 |
Why?
|
| Pancreatic Function Tests | 2 | 1988 | 6 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2011 | 175 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 597 | 0.080 |
Why?
|
| Prevalence | 2 | 2009 | 1609 | 0.080 |
Why?
|
| Adenocarcinoma | 3 | 1995 | 475 | 0.080 |
Why?
|
| Probability | 3 | 2009 | 244 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 207 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2010 | 291 | 0.080 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 498 | 0.080 |
Why?
|
| Smoking Prevention | 1 | 1990 | 259 | 0.080 |
Why?
|
| Intestinal Mucosa | 4 | 2002 | 219 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1990 | 131 | 0.080 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2008 | 10 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 1993 | 445 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2008 | 63 | 0.080 |
Why?
|
| Los Angeles | 3 | 1992 | 30 | 0.080 |
Why?
|
| Pyridines | 1 | 1990 | 261 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2010 | 254 | 0.080 |
Why?
|
| Tissue Donors | 1 | 1990 | 195 | 0.080 |
Why?
|
| Electric Power Supplies | 2 | 2005 | 26 | 0.080 |
Why?
|
| Hospitalization | 3 | 2013 | 977 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2010 | 311 | 0.080 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2007 | 3 | 0.080 |
Why?
|
| Peritoneal Diseases | 1 | 2007 | 6 | 0.080 |
Why?
|
| Health Promotion | 1 | 1992 | 407 | 0.080 |
Why?
|
| Attitude to Health | 1 | 1990 | 403 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 1 | 1990 | 164 | 0.070 |
Why?
|
| Mutation | 4 | 2012 | 1213 | 0.070 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 7 | 0.070 |
Why?
|
| Gastroscopes | 1 | 2007 | 2 | 0.070 |
Why?
|
| Pericardium | 1 | 2008 | 97 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 1990 | 272 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 1992 | 581 | 0.070 |
Why?
|
| Bacteremia | 1 | 2009 | 155 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 1990 | 286 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 1989 | 150 | 0.070 |
Why?
|
| Biomarkers | 1 | 1992 | 1593 | 0.070 |
Why?
|
| Sclerosing Solutions | 1 | 2006 | 6 | 0.070 |
Why?
|
| Esophageal Achalasia | 1 | 2007 | 78 | 0.070 |
Why?
|
| Pancreatic Cyst | 2 | 1985 | 16 | 0.070 |
Why?
|
| Leukocyte Count | 3 | 1991 | 94 | 0.070 |
Why?
|
| Choledochal Cyst | 2 | 2004 | 4 | 0.070 |
Why?
|
| Endometritis | 1 | 2006 | 29 | 0.070 |
Why?
|
| Oleic Acids | 1 | 2006 | 40 | 0.070 |
Why?
|
| Rectal Neoplasms | 2 | 1997 | 75 | 0.070 |
Why?
|
| Malabsorption Syndromes | 2 | 1985 | 7 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2010 | 283 | 0.070 |
Why?
|
| Transillumination | 1 | 2006 | 2 | 0.070 |
Why?
|
| Esophageal Perforation | 2 | 2006 | 13 | 0.070 |
Why?
|
| Preoperative Care | 3 | 1996 | 275 | 0.070 |
Why?
|
| Needles | 1 | 2006 | 34 | 0.070 |
Why?
|
| Barium Sulfate | 6 | 1983 | 66 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2012 | 467 | 0.070 |
Why?
|
| Rectum | 3 | 2002 | 62 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2006 | 51 | 0.070 |
Why?
|
| Intraoperative Period | 1 | 2006 | 62 | 0.070 |
Why?
|
| Splenectomy | 1 | 2006 | 40 | 0.070 |
Why?
|
| Drug Design | 1 | 2006 | 107 | 0.070 |
Why?
|
| Mucous Membrane | 4 | 2007 | 66 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 101 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 3 | 1993 | 503 | 0.070 |
Why?
|
| Brain | 2 | 1994 | 2176 | 0.070 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2005 | 17 | 0.070 |
Why?
|
| Hemostatic Techniques | 1 | 2005 | 23 | 0.070 |
Why?
|
| Diazepam | 2 | 1983 | 23 | 0.060 |
Why?
|
| Colon | 1 | 2006 | 168 | 0.060 |
Why?
|
| Exercise | 1 | 1991 | 658 | 0.060 |
Why?
|
| Heartburn | 1 | 2005 | 46 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 627 | 0.060 |
Why?
|
| Fallopian Tubes | 1 | 2005 | 11 | 0.060 |
Why?
|
| Gastrectomy | 2 | 1984 | 24 | 0.060 |
Why?
|
| Models, Animal | 4 | 2007 | 252 | 0.060 |
Why?
|
| Monitoring, Physiologic | 3 | 1991 | 219 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 3 | 2003 | 318 | 0.060 |
Why?
|
| Hot Temperature | 1 | 1985 | 152 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 438 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 1998 | 172 | 0.060 |
Why?
|
| Syndrome | 3 | 1994 | 255 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 1999 | 193 | 0.060 |
Why?
|
| Electrosurgery | 1 | 2005 | 15 | 0.060 |
Why?
|
| Methylcellulose | 1 | 2004 | 6 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 16 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 301 | 0.060 |
Why?
|
| Neoplasm Seeding | 1 | 1984 | 7 | 0.060 |
Why?
|
| Middle East | 2 | 1994 | 17 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 5 | 1992 | 219 | 0.060 |
Why?
|
| Radiology, Interventional | 2 | 1997 | 21 | 0.060 |
Why?
|
| Dogs | 5 | 1994 | 490 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2005 | 69 | 0.060 |
Why?
|
| Radiology | 1 | 2005 | 97 | 0.060 |
Why?
|
| In Vitro Techniques | 5 | 2005 | 765 | 0.060 |
Why?
|
| Constriction, Pathologic | 4 | 1994 | 236 | 0.060 |
Why?
|
| Celiac Plexus | 1 | 1983 | 2 | 0.060 |
Why?
|
| Esophagoscopes | 1 | 2003 | 5 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 1984 | 45 | 0.060 |
Why?
|
| Autonomic Nerve Block | 1 | 1983 | 15 | 0.060 |
Why?
|
| North Carolina | 2 | 1995 | 224 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 1983 | 32 | 0.060 |
Why?
|
| Women's Rights | 2 | 1994 | 5 | 0.060 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 1996 | 9 | 0.060 |
Why?
|
| Ligation | 3 | 2005 | 83 | 0.060 |
Why?
|
| Hematemesis | 2 | 1973 | 14 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 2003 | 57 | 0.060 |
Why?
|
| Alcohol Drinking | 2 | 2008 | 805 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 2 | 1981 | 48 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1995 | 624 | 0.060 |
Why?
|
| South Carolina | 3 | 2009 | 2752 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 1983 | 107 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 1983 | 130 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 1992 | 1032 | 0.050 |
Why?
|
| Prejudice | 2 | 1993 | 37 | 0.050 |
Why?
|
| Weight Loss | 1 | 2005 | 319 | 0.050 |
Why?
|
| Dilatation, Pathologic | 2 | 1999 | 58 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2000 | 85 | 0.050 |
Why?
|
| Digestive System | 2 | 1997 | 35 | 0.050 |
Why?
|
| Cost Control | 2 | 1992 | 34 | 0.050 |
Why?
|
| Pancreatectomy | 3 | 1988 | 129 | 0.050 |
Why?
|
| Hemorrhage | 3 | 1991 | 328 | 0.050 |
Why?
|
| Wounds, Gunshot | 2 | 1992 | 48 | 0.050 |
Why?
|
| Duodenal Ulcer | 5 | 1985 | 16 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 1984 | 247 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2001 | 52 | 0.050 |
Why?
|
| State Government | 2 | 1992 | 34 | 0.050 |
Why?
|
| Antitrust Laws | 2 | 1991 | 2 | 0.050 |
Why?
|
| Glycine | 1 | 2001 | 89 | 0.050 |
Why?
|
| Steroids | 2 | 1993 | 84 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2001 | 40 | 0.050 |
Why?
|
| Epidemiologic Methods | 2 | 2012 | 83 | 0.050 |
Why?
|
| Age Distribution | 1 | 2002 | 319 | 0.050 |
Why?
|
| Zalcitabine | 2 | 1990 | 4 | 0.050 |
Why?
|
| Hospital Departments | 1 | 2000 | 15 | 0.050 |
Why?
|
| Observer Variation | 1 | 2001 | 330 | 0.050 |
Why?
|
| Urologists | 1 | 2020 | 7 | 0.050 |
Why?
|
| Sepsis | 1 | 1983 | 233 | 0.050 |
Why?
|
| Urban Population | 2 | 1992 | 254 | 0.050 |
Why?
|
| Prosthesis Failure | 3 | 2009 | 130 | 0.050 |
Why?
|
| Colonic Diseases | 2 | 1997 | 36 | 0.050 |
Why?
|
| Anemia | 1 | 2001 | 104 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2001 | 144 | 0.050 |
Why?
|
| ROC Curve | 1 | 2001 | 392 | 0.050 |
Why?
|
| Liver Neoplasms | 3 | 1995 | 334 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 1984 | 375 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2009 | 799 | 0.040 |
Why?
|
| Stomach Ulcer | 3 | 1985 | 14 | 0.040 |
Why?
|
| Lipids | 2 | 1972 | 298 | 0.040 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 2 | 2010 | 10 | 0.040 |
Why?
|
| Reoperation | 4 | 2006 | 467 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2000 | 1040 | 0.040 |
Why?
|
| Adenoma | 2 | 1991 | 132 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 1981 | 157 | 0.040 |
Why?
|
| Exons | 2 | 2010 | 122 | 0.040 |
Why?
|
| Minority Groups | 2 | 1992 | 196 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2001 | 330 | 0.040 |
Why?
|
| Diathermy | 1 | 1979 | 5 | 0.040 |
Why?
|
| Glucagon | 1 | 1979 | 22 | 0.040 |
Why?
|
| Decision Trees | 1 | 1999 | 74 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1999 | 60 | 0.040 |
Why?
|
| Confidence Intervals | 3 | 2007 | 242 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1999 | 47 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2001 | 383 | 0.040 |
Why?
|
| Bacterial Adhesion | 2 | 1996 | 33 | 0.040 |
Why?
|
| Safety | 2 | 2005 | 145 | 0.040 |
Why?
|
| Registries | 1 | 2002 | 730 | 0.040 |
Why?
|
| Rats | 5 | 1996 | 5300 | 0.040 |
Why?
|
| Posture | 3 | 1975 | 107 | 0.040 |
Why?
|
| Punctures | 3 | 1989 | 35 | 0.040 |
Why?
|
| Quality Control | 1 | 1998 | 81 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 626 | 0.040 |
Why?
|
| Consensus | 1 | 2019 | 211 | 0.040 |
Why?
|
| Decision Making | 1 | 2001 | 410 | 0.040 |
Why?
|
| Thymoma | 1 | 1997 | 14 | 0.040 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1997 | 7 | 0.040 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 17 | 0.040 |
Why?
|
| Medical Laboratory Science | 1 | 1997 | 8 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1997 | 15 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 1995 | 14 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 1997 | 9 | 0.040 |
Why?
|
| Liver Diseases | 3 | 1992 | 193 | 0.040 |
Why?
|
| Triage | 1 | 1998 | 109 | 0.040 |
Why?
|
| Diagnostic Errors | 2 | 1988 | 100 | 0.030 |
Why?
|
| Antipruritics | 1 | 1996 | 3 | 0.030 |
Why?
|
| Laser Therapy | 2 | 1990 | 54 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 689 | 0.030 |
Why?
|
| Pruritus | 1 | 1996 | 35 | 0.030 |
Why?
|
| Biofilms | 1 | 1996 | 72 | 0.030 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 546 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 66 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 1996 | 41 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 1995 | 38 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 46 | 0.030 |
Why?
|
| Adenoma, Bile Duct | 3 | 1991 | 3 | 0.030 |
Why?
|
| Vasomotor System | 1 | 1995 | 5 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 1995 | 20 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 159 | 0.030 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1975 | 7 | 0.030 |
Why?
|
| Hookworm Infections | 1 | 1975 | 2 | 0.030 |
Why?
|
| Oregon | 1 | 1995 | 7 | 0.030 |
Why?
|
| Value of Life | 1 | 1995 | 14 | 0.030 |
Why?
|
| Euthanasia, Active, Voluntary | 1 | 1995 | 7 | 0.030 |
Why?
|
| Judicial Role | 1 | 1995 | 6 | 0.030 |
Why?
|
| Equipment Safety | 2 | 2006 | 50 | 0.030 |
Why?
|
| Cholangiocarcinoma | 1 | 1995 | 20 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 1995 | 18 | 0.030 |
Why?
|
| Glatiramer Acetate | 1 | 1994 | 5 | 0.030 |
Why?
|
| Interferon beta-1a | 1 | 1994 | 4 | 0.030 |
Why?
|
| Information Systems | 1 | 1995 | 45 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 57 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1995 | 61 | 0.030 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1995 | 73 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1995 | 89 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 1995 | 90 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1996 | 368 | 0.030 |
Why?
|
| Compensation and Redress | 1 | 1994 | 8 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 1994 | 12 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 314 | 0.030 |
Why?
|
| Naltrexone | 1 | 1996 | 195 | 0.030 |
Why?
|
| Asia | 1 | 1994 | 59 | 0.030 |
Why?
|
| Contraindications | 1 | 1994 | 52 | 0.030 |
Why?
|
| Gulf War | 1 | 1994 | 22 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 1994 | 5 | 0.030 |
Why?
|
| Control Groups | 1 | 1994 | 10 | 0.030 |
Why?
|
| Budgets | 1 | 1994 | 12 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 1994 | 7 | 0.030 |
Why?
|
| Awareness | 1 | 1994 | 81 | 0.030 |
Why?
|
| Animal Rights | 1 | 1993 | 1 | 0.030 |
Why?
|
| Choledochostomy | 2 | 1995 | 10 | 0.030 |
Why?
|
| Cytological Techniques | 1 | 1994 | 23 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 1994 | 27 | 0.030 |
Why?
|
| Animals, Laboratory | 1 | 1993 | 21 | 0.030 |
Why?
|
| Jaundice, Obstructive | 1 | 2013 | 8 | 0.030 |
Why?
|
| Community Participation | 1 | 1994 | 42 | 0.030 |
Why?
|
| Pest Control | 1 | 1993 | 2 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 74 | 0.030 |
Why?
|
| Cuba | 1 | 1993 | 8 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1993 | 31 | 0.030 |
Why?
|
| Birds | 1 | 1993 | 17 | 0.030 |
Why?
|
| Propofol | 1 | 1994 | 36 | 0.030 |
Why?
|
| Nervous System | 1 | 1993 | 45 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 1994 | 64 | 0.030 |
Why?
|
| Midwestern United States | 1 | 1993 | 36 | 0.030 |
Why?
|
| Culicidae | 1 | 1993 | 12 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 1994 | 147 | 0.030 |
Why?
|
| Nutrition Disorders | 1 | 1993 | 16 | 0.030 |
Why?
|
| San Francisco | 1 | 1993 | 3 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1994 | 54 | 0.030 |
Why?
|
| Ethacrynic Acid | 1 | 1993 | 16 | 0.030 |
Why?
|
| Melena | 1 | 1973 | 8 | 0.030 |
Why?
|
| Information Services | 1 | 1993 | 22 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1993 | 86 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1993 | 28 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 648 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 1993 | 49 | 0.030 |
Why?
|
| Length of Stay | 2 | 1994 | 780 | 0.030 |
Why?
|
| Retroviridae Infections | 1 | 1993 | 7 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 1994 | 142 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 1993 | 22 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1994 | 115 | 0.030 |
Why?
|
| Duodenal Neoplasms | 2 | 1988 | 9 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 1994 | 1533 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 238 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1994 | 328 | 0.030 |
Why?
|
| Ibotenic Acid | 1 | 1992 | 9 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1992 | 21 | 0.030 |
Why?
|
| Gingival Hemorrhage | 1 | 1992 | 10 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1995 | 358 | 0.030 |
Why?
|
| Reference Values | 2 | 1997 | 579 | 0.030 |
Why?
|
| Iraq | 1 | 1992 | 24 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 188 | 0.030 |
Why?
|
| Abortion, Legal | 1 | 1992 | 3 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1992 | 44 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 1992 | 26 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1992 | 57 | 0.030 |
Why?
|
| Social Values | 1 | 1992 | 34 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1994 | 215 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 1992 | 58 | 0.030 |
Why?
|
| Wounds, Stab | 1 | 1992 | 7 | 0.030 |
Why?
|
| Cannabis | 1 | 1994 | 115 | 0.030 |
Why?
|
| Vitamins | 1 | 1993 | 134 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 1992 | 51 | 0.030 |
Why?
|
| Homozygote | 1 | 2012 | 119 | 0.030 |
Why?
|
| Diatrizoate | 1 | 1992 | 2 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2012 | 207 | 0.030 |
Why?
|
| Legislation, Medical | 1 | 1992 | 8 | 0.030 |
Why?
|
| Ultrasonics | 2 | 1989 | 17 | 0.030 |
Why?
|
| Computers | 1 | 1992 | 63 | 0.030 |
Why?
|
| Electrocardiography | 1 | 1995 | 601 | 0.030 |
Why?
|
| Scotland | 1 | 2012 | 18 | 0.030 |
Why?
|
| Police | 1 | 1992 | 34 | 0.030 |
Why?
|
| Skin Temperature | 1 | 1992 | 24 | 0.030 |
Why?
|
| Maryland | 1 | 1992 | 77 | 0.030 |
Why?
|
| Neoplasms | 4 | 1993 | 1664 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1992 | 86 | 0.030 |
Why?
|
| Medicare Part B | 1 | 1991 | 3 | 0.030 |
Why?
|
| Poly U | 1 | 1991 | 1 | 0.030 |
Why?
|
| Alopecia | 1 | 1992 | 45 | 0.030 |
Why?
|
| Measles Vaccine | 1 | 1991 | 3 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2012 | 87 | 0.030 |
Why?
|
| Expert Testimony | 1 | 1992 | 47 | 0.030 |
Why?
|
| Mentors | 1 | 1992 | 81 | 0.030 |
Why?
|
| Iohexol | 1 | 1992 | 82 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1994 | 269 | 0.030 |
Why?
|
| Sputum | 1 | 2012 | 51 | 0.030 |
Why?
|
| Computer Systems | 1 | 1991 | 42 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1992 | 112 | 0.030 |
Why?
|
| Poly I-C | 1 | 1991 | 20 | 0.030 |
Why?
|
| Toxoplasmosis | 1 | 1991 | 13 | 0.030 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1991 | 11 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1991 | 24 | 0.020 |
Why?
|
| Fatigue | 1 | 1992 | 132 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1991 | 124 | 0.020 |
Why?
|
| Macrolides | 1 | 1991 | 48 | 0.020 |
Why?
|
| West Virginia | 1 | 1991 | 11 | 0.020 |
Why?
|
| Catastrophic Illness | 1 | 1991 | 1 | 0.020 |
Why?
|
| Insurance, Major Medical | 1 | 1991 | 1 | 0.020 |
Why?
|
| Gallbladder Neoplasms | 1 | 1991 | 6 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1991 | 31 | 0.020 |
Why?
|
| Amenorrhea | 1 | 1991 | 16 | 0.020 |
Why?
|
| Patient Participation | 1 | 1993 | 145 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 1991 | 42 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 1992 | 109 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1991 | 57 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 240 | 0.020 |
Why?
|
| Workers' Compensation | 1 | 1991 | 3 | 0.020 |
Why?
|
| Altruism | 1 | 1991 | 24 | 0.020 |
Why?
|
| Agranulocytosis | 1 | 1991 | 15 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 782 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 1991 | 15 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 397 | 0.020 |
Why?
|
| Fees, Pharmaceutical | 1 | 1991 | 7 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 91 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1991 | 47 | 0.020 |
Why?
|
| Social Control, Formal | 1 | 1991 | 12 | 0.020 |
Why?
|
| Mandatory Programs | 1 | 1991 | 8 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 1992 | 127 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1992 | 84 | 0.020 |
Why?
|
| Suction | 1 | 1991 | 33 | 0.020 |
Why?
|
| Nose | 1 | 1991 | 36 | 0.020 |
Why?
|
| Mentally Ill Persons | 1 | 1991 | 14 | 0.020 |
Why?
|
| Propranolol | 1 | 1991 | 102 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1991 | 22 | 0.020 |
Why?
|
| Cause of Death | 1 | 1992 | 241 | 0.020 |
Why?
|
| Obstetrics | 1 | 1991 | 44 | 0.020 |
Why?
|
| Mycoses | 1 | 1991 | 60 | 0.020 |
Why?
|
| Mucus | 1 | 1991 | 33 | 0.020 |
Why?
|
| Vision Tests | 1 | 1990 | 18 | 0.020 |
Why?
|
| Community Health Services | 1 | 1992 | 141 | 0.020 |
Why?
|
| Foscarnet | 1 | 1990 | 3 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2010 | 4 | 0.020 |
Why?
|
| Phosphonoacetic Acid | 1 | 1990 | 5 | 0.020 |
Why?
|
| Perfusion | 2 | 2005 | 131 | 0.020 |
Why?
|
| Dilatation | 2 | 1982 | 58 | 0.020 |
Why?
|
| Lithotripsy, Laser | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 1991 | 85 | 0.020 |
Why?
|
| Prostatectomy | 1 | 1991 | 87 | 0.020 |
Why?
|
| Consumer Behavior | 1 | 1991 | 68 | 0.020 |
Why?
|
| Selegiline | 1 | 1990 | 3 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2012 | 199 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 1991 | 63 | 0.020 |
Why?
|
| New York | 1 | 1991 | 223 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1990 | 20 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1990 | 18 | 0.020 |
Why?
|
| Nociceptors | 1 | 1990 | 9 | 0.020 |
Why?
|
| Quinolinic Acid | 1 | 1990 | 11 | 0.020 |
Why?
|
| Aminosalicylic Acids | 1 | 1990 | 2 | 0.020 |
Why?
|
| Diabetes Complications | 2 | 2009 | 249 | 0.020 |
Why?
|
| Laryngeal Mucosa | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ointments | 1 | 1990 | 15 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1990 | 10 | 0.020 |
Why?
|
| Placebo Effect | 1 | 1990 | 20 | 0.020 |
Why?
|
| Anxiety | 1 | 2014 | 422 | 0.020 |
Why?
|
| Vitamin E | 1 | 1990 | 55 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 1990 | 14 | 0.020 |
Why?
|
| Mesalamine | 1 | 1990 | 6 | 0.020 |
Why?
|
| Alaska | 1 | 1990 | 7 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 1990 | 33 | 0.020 |
Why?
|
| Retroviridae Proteins | 1 | 1990 | 5 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 1990 | 11 | 0.020 |
Why?
|
| Fish Oils | 1 | 1990 | 21 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1991 | 254 | 0.020 |
Why?
|
| England | 1 | 1990 | 64 | 0.020 |
Why?
|
| Epiglottis | 1 | 1990 | 11 | 0.020 |
Why?
|
| Women | 1 | 1990 | 40 | 0.020 |
Why?
|
| Bone Density | 1 | 1991 | 159 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 1992 | 209 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 1990 | 48 | 0.020 |
Why?
|
| Tryptophan | 1 | 1990 | 65 | 0.020 |
Why?
|
| Menstruation | 1 | 1990 | 20 | 0.020 |
Why?
|
| Directed Tissue Donation | 1 | 1990 | 5 | 0.020 |
Why?
|
| Calcitonin | 1 | 1990 | 21 | 0.020 |
Why?
|
| Nursing Records | 1 | 1990 | 10 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1990 | 77 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1993 | 470 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 1990 | 143 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1990 | 49 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1990 | 46 | 0.020 |
Why?
|
| Diet | 1 | 1993 | 514 | 0.020 |
Why?
|
| Drug Therapy | 1 | 1990 | 71 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1990 | 105 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 1990 | 70 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1988 | 351 | 0.020 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1989 | 8 | 0.020 |
Why?
|
| Emotions | 1 | 1991 | 244 | 0.020 |
Why?
|
| Software | 1 | 1992 | 418 | 0.020 |
Why?
|
| Hepatic Artery | 1 | 1989 | 25 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 807 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 507 | 0.020 |
Why?
|
| Terminally Ill | 1 | 2009 | 17 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 294 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 1990 | 91 | 0.020 |
Why?
|
| Melanoma | 1 | 1973 | 335 | 0.020 |
Why?
|
| Stainless Steel | 1 | 2009 | 31 | 0.020 |
Why?
|
| Bias | 1 | 1990 | 148 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 424 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1015 | 0.020 |
Why?
|
| Choristoma | 1 | 1988 | 20 | 0.020 |
Why?
|
| Alloys | 1 | 2009 | 66 | 0.020 |
Why?
|
| Angiography | 1 | 1989 | 194 | 0.020 |
Why?
|
| Cobalt Radioisotopes | 1 | 1988 | 4 | 0.020 |
Why?
|
| Proteins | 3 | 1979 | 473 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 447 | 0.020 |
Why?
|
| Atrophy | 2 | 1985 | 112 | 0.020 |
Why?
|
| Pleural Cavity | 1 | 2008 | 1 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1446 | 0.020 |
Why?
|
| Wound Healing | 1 | 1990 | 260 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 1994 | 696 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 536 | 0.020 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2007 | 22 | 0.020 |
Why?
|
| Patient Compliance | 1 | 1990 | 402 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 714 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2265 | 0.020 |
Why?
|
| Muscles | 1 | 2007 | 158 | 0.020 |
Why?
|
| Depression | 1 | 2014 | 942 | 0.020 |
Why?
|
| Mouth | 1 | 2007 | 64 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 83 | 0.020 |
Why?
|
| Gastrins | 1 | 1986 | 27 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1992 | 2455 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1991 | 596 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1986 | 149 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1986 | 196 | 0.020 |
Why?
|
| Serotonin | 1 | 1986 | 144 | 0.020 |
Why?
|
| Heart Failure | 1 | 1995 | 1179 | 0.020 |
Why?
|
| Shear Strength | 1 | 2005 | 15 | 0.020 |
Why?
|
| Cell Division | 1 | 1986 | 541 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 179 | 0.020 |
Why?
|
| Cholecystokinin | 2 | 1975 | 29 | 0.020 |
Why?
|
| Manikins | 1 | 2005 | 42 | 0.020 |
Why?
|
| Alleles | 1 | 2006 | 386 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2005 | 90 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 301 | 0.020 |
Why?
|
| Microcomputers | 1 | 2005 | 32 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1991 | 551 | 0.020 |
Why?
|
| Hypromellose Derivatives | 1 | 2004 | 2 | 0.020 |
Why?
|
| Arteries | 1 | 2005 | 108 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 1984 | 7 | 0.020 |
Why?
|
| Thioridazine | 1 | 1984 | 6 | 0.020 |
Why?
|
| Fluphenazine | 1 | 1984 | 19 | 0.020 |
Why?
|
| Pedigree | 1 | 1984 | 159 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 791 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1984 | 7 | 0.010 |
Why?
|
| Advisory Committees | 1 | 2004 | 73 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 63 | 0.010 |
Why?
|
| Gastritis, Atrophic | 1 | 1983 | 1 | 0.010 |
Why?
|
| Haloperidol | 1 | 1984 | 95 | 0.010 |
Why?
|
| Hepatitis A | 2 | 1973 | 8 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1983 | 15 | 0.010 |
Why?
|
| Myocardium | 1 | 1990 | 1204 | 0.010 |
Why?
|
| Amnesia | 1 | 1983 | 17 | 0.010 |
Why?
|
| Emergencies | 2 | 1981 | 107 | 0.010 |
Why?
|
| Enema | 1 | 1983 | 23 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 222 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 785 | 0.010 |
Why?
|
| Midazolam | 1 | 1983 | 46 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 2003 | 61 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 249 | 0.010 |
Why?
|
| Nitrosamines | 1 | 1982 | 18 | 0.010 |
Why?
|
| Nitrites | 1 | 1982 | 53 | 0.010 |
Why?
|
| Infection Control | 1 | 1983 | 101 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1984 | 307 | 0.010 |
Why?
|
| Lasers | 1 | 1981 | 61 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 981 | 0.010 |
Why?
|
| Bacteria | 3 | 1988 | 193 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 1979 | 10 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 47 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 1979 | 15 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1979 | 75 | 0.010 |
Why?
|
| DNA | 2 | 1972 | 597 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1979 | 102 | 0.010 |
Why?
|
| Mass Screening | 1 | 2004 | 838 | 0.010 |
Why?
|
| Chymotrypsinogen | 2 | 1975 | 2 | 0.010 |
Why?
|
| Arginine | 1 | 1979 | 102 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1979 | 87 | 0.010 |
Why?
|
| Amylases | 2 | 1975 | 17 | 0.010 |
Why?
|
| Defecation | 1 | 1997 | 8 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1997 | 17 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1997 | 52 | 0.010 |
Why?
|
| Anal Canal | 1 | 1997 | 20 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1977 | 35 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1997 | 91 | 0.010 |
Why?
|
| 5'-Nucleotidase | 1 | 1996 | 13 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 369 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 104 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 134 | 0.010 |
Why?
|
| Ceruletide | 1 | 1975 | 8 | 0.010 |
Why?
|
| Insulin | 1 | 1979 | 617 | 0.010 |
Why?
|
| Hydrolases | 1 | 1975 | 20 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1995 | 15 | 0.010 |
Why?
|
| Tunisia | 1 | 1975 | 2 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1996 | 223 | 0.010 |
Why?
|
| Consciousness | 1 | 1974 | 17 | 0.010 |
Why?
|
| Chlorides | 1 | 1974 | 68 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 492 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 852 | 0.010 |
Why?
|
| Potassium | 1 | 1974 | 168 | 0.010 |
Why?
|
| Sodium | 1 | 1974 | 161 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1973 | 30 | 0.010 |
Why?
|
| Postgastrectomy Syndromes | 1 | 1972 | 2 | 0.010 |
Why?
|
| Economics, Medical | 1 | 1972 | 8 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1994 | 210 | 0.010 |
Why?
|
| Cell Survival | 1 | 1996 | 901 | 0.010 |
Why?
|
| Hepatitis | 1 | 1972 | 25 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1972 | 52 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1972 | 20 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1972 | 38 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1972 | 48 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1972 | 41 | 0.010 |
Why?
|
| Neutrophils | 1 | 1973 | 204 | 0.010 |
Why?
|
| Feces | 1 | 1972 | 88 | 0.010 |
Why?
|
| Triglycerides | 1 | 1972 | 184 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 929 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1972 | 186 | 0.010 |
Why?
|
| Laparotomy | 1 | 1991 | 65 | 0.010 |
Why?
|
| Cholesterol | 1 | 1972 | 331 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1973 | 431 | 0.010 |
Why?
|
| Fasting | 1 | 1970 | 75 | 0.010 |
Why?
|
| Germany, West | 1 | 1989 | 3 | 0.010 |
Why?
|
| Premedication | 1 | 1989 | 49 | 0.010 |
Why?
|
| Pancreatic Extracts | 1 | 1988 | 1 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1991 | 444 | 0.000 |
Why?
|
| Enterobacteriaceae | 1 | 1988 | 29 | 0.000 |
Why?
|
| Crystallization | 1 | 1988 | 57 | 0.000 |
Why?
|
| Pain, Intractable | 1 | 1988 | 28 | 0.000 |
Why?
|
| Microscopy | 1 | 1988 | 64 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1988 | 236 | 0.000 |
Why?
|
| Data Interpretation, Statistical | 1 | 1989 | 329 | 0.000 |
Why?
|
| Inflammation | 1 | 1973 | 1030 | 0.000 |
Why?
|
| Employment | 1 | 1988 | 154 | 0.000 |
Why?
|
| Classification | 1 | 1984 | 8 | 0.000 |
Why?
|
| Duodenitis | 1 | 1984 | 1 | 0.000 |
Why?
|
| Electrodes | 1 | 1984 | 147 | 0.000 |
Why?
|
| Diarrhea | 1 | 1984 | 63 | 0.000 |
Why?
|
| Nitrates | 1 | 1982 | 61 | 0.000 |
Why?
|
| Gastric Acid | 1 | 1982 | 71 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 618 | 0.000 |
Why?
|
| Anemia, Hypochromic | 1 | 1979 | 3 | 0.000 |
Why?
|
| Half-Life | 1 | 1975 | 96 | 0.000 |
Why?
|
| Glutaral | 1 | 1974 | 41 | 0.000 |
Why?
|
| Aldehydes | 1 | 1974 | 34 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1974 | 42 | 0.000 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1974 | 133 | 0.000 |
Why?
|
| Tomography | 1 | 1972 | 9 | 0.000 |
Why?
|
| Hypoventilation | 1 | 1972 | 8 | 0.000 |
Why?
|
| Pneumonia, Aspiration | 1 | 1972 | 22 | 0.000 |
Why?
|
| Sutures | 1 | 1972 | 32 | 0.000 |
Why?
|
| Hypotension | 1 | 1972 | 74 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1972 | 306 | 0.000 |
Why?
|
| Ethanol | 1 | 1974 | 892 | 0.000 |
Why?
|